Holen Sie sich die Stockscreener-App
2.43
2.02%
-0.05
Handel nachbörslich:
2.44
0.010
+0.41%
Schlusskurs vom Vortag:
$2.48
Offen:
$2.52
24-Stunden-Volumen:
4.90M
Relative Volume:
3.77
Marktkapitalisierung:
$689.32M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-125.04M
KGV:
-2.9634
EPS:
-0.82
Netto-Cashflow:
$-122.99M
1W Leistung:
+9.95%
1M Leistung:
+56.77%
6M Leistung:
+129.25%
1J Leistung:
-3.57%
1-Tages-Spanne:
$2.41
$2.765
1-Wochen-Bereich:
$2.125
$2.765
52-Wochen-Spanne:
$1.01
$3.305
Erasca Inc Stock (ERAS) Company Profile
Firmenname
Erasca Inc
Sektor
Branche
Telefon
(858) 465-6511
Adresse
3115 MERRYFIELD ROW, SAN DIEGO
Vergleichen Sie ERAS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ERAS
Erasca Inc
|
2.43 | 703.50M | 0 | -125.04M | -122.99M | -0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Erasca Inc Stock (ERAS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-26 | Eingeleitet | Raymond James | Outperform |
| 2024-11-18 | Eingeleitet | Jefferies | Buy |
| 2024-03-11 | Eingeleitet | CapitalOne | Overweight |
| 2024-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-10-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-03-30 | Eingeleitet | Mizuho | Buy |
| 2023-02-24 | Eingeleitet | Goldman | Buy |
| 2023-02-03 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Erasca Inc Aktie (ERAS) Neueste Nachrichten
Will Erasca Inc. price bounce be sustainableIndex Update & Accurate Entry/Exit Alerts - newser.com
Why Erasca Inc. stock remains on buy lists2025 Year in Review & Fast Gain Stock Trading Tips - newser.com
Will Erasca Inc. stock benefit from upcoming earnings reportsJuly 2025 Short Interest & Low Risk High Reward Ideas - newser.com
Can swing trading help recover from Erasca Inc. losses2025 Price Momentum & Community Driven Trade Alerts - newser.com
Why retail investors favor Erasca Inc. stockMarket Performance Summary & Weekly High Conviction Ideas - newser.com
Erasca: Hype Building Into The End Of The Year (Rating Downgrade) (NASDAQ:ERAS) - Seeking Alpha
Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket - Benzinga
What drives Erasca Inc stock priceMarket Rumors and News & High Return Stock Ideas - earlytimes.in
Erasca Inc Stock Analysis and ForecastBreakout Stock Watch & Interactive Charts for Smarter Trading - earlytimes.in
Erasca, Inc. (NASDAQ:ERAS) Receives $3.71 Consensus PT from Analysts - Defense World
Key resistance and support levels for Erasca Inc.Weekly Profit Summary & AI Driven Stock Price Forecasts - newser.com
Wall Street Zen Upgrades Erasca (NASDAQ:ERAS) to Hold - Defense World
Finanzdaten der Erasca Inc-Aktie (ERAS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.05%
4.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):